eHealth Earnings Call: Profits Up, 2026 As Bridge Year

Ehealth ((EHTH)) has held its Q4 earnings call. Read on for the main highlights of the call.

eHealth’s latest earnings call struck a cautiously upbeat tone, mixing robust 2025 profit gains with a deliberate plan to sacrifice near‑term growth in 2026. Management highlighted sharp improvements in LTV, margins and technology while openly labeling 2026 a “bridge year” focused on cash flow and efficiency amid persistent industry commission pressure.

Revenue Growth and Record Quarter

Total revenue for 2025 rose 4% to $554.0 million, with fourth‑quarter revenue also up 4% to a record $326.2 million. The top‑line expansion was modest but notable given a tough Medicare environment and carrier pullbacks that weighed on industry volumes.

Material Improvement in Profitability

Profitability was the headline driver, with full‑year GAAP net income nearly quadrupling to $40.0 million and adjusted EBITDA up 40% to $97.3 million. In Q4, adjusted EBITDA increased 10% year over year to $132.9 million, underscoring stronger unit economics and cost discipline.

Medicare Segment Strength

Medicare remained the core engine, with full‑year segment revenue up 6% to $531.2 million and Q4 Medicare revenue up 5% to $319.6 million. Medicare gross profit grew even faster, rising 21% for the year and 12% in Q4 to $178.3 million, showing expanding margins in the flagship business.

Improved LTV and Enrollment Efficiency

The economics of new policies improved meaningfully, as Medicare Advantage LTV climbed 11% in Q4 2025. The company’s LTV‑to‑CAC ratio reached 2.2x versus 2.0x a year earlier, signaling better payback and healthier margins on each new member enrolled.

Record Commissions Receivable Base

Total commissions receivable ended 2025 at a record $1.1 billion, up 12% year over year and highlighting substantial future cash‑collection potential. This growing asset base is central to the company’s strategy, even as actual cash inflows depend on carrier payment timing.

Ancillary Product Momentum

Ancillary products were a bright spot, led by hospital indemnity plans with approved applications jumping over 400% in Q4 and more than quintupling for the year to over 30,000 members. Medicare Supplement applications also gained traction, rising 39% in Q4 and diversifying revenue beyond core Medicare Advantage.

Operational and Cost Discipline

Management detailed an aggressive cost‑cutting program for 2026, targeting roughly $30 million of fixed cost savings, or about 20% below 2025 levels. Variable spending is set to shrink by more than $60 million, for total year‑over‑year spend reductions exceeding $90 million to support margin and cash flow.

AI and Technology Differentiation

Technology featured prominently, with an AI screener scaled during AEP that reduced wait times and matched or beat human screeners on transfer and conversion rates. Management framed AI as a key competitive advantage, with more automation and decision‑support tools expected to follow.

Capital and Liquidity Actions

The company shored up liquidity by securing a $125 million revolving credit facility and using it in part to repay $70.7 million of term debt. Year‑end cash, equivalents and marketable securities stood at $77.2 million, giving eHealth added flexibility to navigate volatility in commission flows.

Expected Revenue and Enrollment Moderation

Management signaled a step back on growth in 2026, with revenue guided down from $554.0 million in 2025 to a range of $405 million to $445 million. Medicare enrollment volumes and non‑commission revenue are expected to decline as the company prioritizes profitability, cash generation and strategic investments.

Decline in Agency Submissions

Medicare Advantage submissions in the agency model fell 3% in Q4, reflecting a managed pullback rather than weaker demand. eHealth is steering away from lower‑margin third‑party channels and toward branded, higher‑quality sources that better support long‑term economics.

Pressure on Carrier‑Driven Revenue Streams

Carrier‑dedicated revenue and sponsorships declined in Q4 amid industry‑wide commission suppression, plan eliminations and carrier exits. Management expects ongoing weakness in BPO and sponsorship income and has already factored this drag into its 2026 outlook.

Employer & Individual Segment Weakness

The Employer and Individual business remained a soft spot, with revenue and profit down in both Q4 and full‑year 2025. The segment is being repositioned toward ICHRA and employer‑centric platforms, creating near‑term headwinds but potentially higher‑value solutions longer term.

Q4 GAAP Net Income Dip

Despite strong operations, Q4 2025 GAAP net income slipped to $87.2 million from $97.5 million a year earlier. Management attributed the decline primarily to a higher effective tax rate, not to deteriorating fundamentals, as revenue and adjusted EBITDA still grew.

Cash and Timing Risk

Year‑end cash of $77.2 million was slightly below the prior year’s $82.2 million, underscoring dependence on the timing of carrier commission payments. For 2026, operating cash flow guidance ranges widely from negative $10 million to positive $12 million, reflecting meaningful timing and execution risk.

Tail Revenue Variability

Tail, or net adjustment, revenue was positive but volatile, at $3.9 million in Q4 versus $7.6 million last year, while full‑year tail revenue nearly doubled to $44.4 million. Management cautioned that future tail is uncertain and built in a conservative $0 to $20 million range for 2026 planning.

Persistent Market Disruption

The company expects the Medicare Advantage “structural reset” to continue through 2026, with ongoing commission pressure, plan exits and narrower carrier relationships. These conditions limit near‑term growth opportunities and heighten the importance of cost control and improved member economics.

Planned Pullback and Growth Trade‑Off

Management was explicit that 2026 will be a deliberate pullback year, reducing spend in lower‑margin areas and accepting lower enrollment and revenue. The strategy aims to exit the year with stronger margins, more resilient cash flow and a more focused channel mix to support future growth.

Guidance and Outlook

For 2026, eHealth guided revenue to $405 million–$445 million, GAAP net income to $8 million–$25 million and adjusted EBITDA to $55 million–$75 million, with operating cash flow between negative $10 million and positive $12 million. The outlook assumes more than $90 million in cost cuts, flat earnings excluding tail, better EBITDA margins and a path to breakeven cash flow in 2026 and positive cash generation in 2027.

eHealth’s earnings call painted a picture of a company trading near‑term growth for durability, leaning on improved profitability, rising LTV and a large commissions receivable base. For investors, the story now hinges on management’s ability to execute its cost‑reduction and technology plans while riding out a choppy Medicare market and proving that 2026 truly is a bridge to stronger, cash‑generative growth.